Key Investor Information This document provides you with key investor information about this fund. It is not marketing material. The information is required by law to help you understand the nature and the risks of investing in this fund. You are advised to read it so you can make an informed decision about whether to invest. Harbor Health Care UCITS ETF (the Fund) – ISIN: IE00BJQTJ848 Accumulating ETF Share Class A sub-fund of HANetf ICAV. Managed by HANetf Management Limited (the Manager) Objectives and Investment Policy The Fund seeks to achieve growth of capital over the medium to opportunities; and long term as its investment objective. The Fund invests primarily •Solid financial controls and accounting processes. in equity securities, principally common and preferred stocks and equity related securities of companies of any market Investment Policy: The fund employs an active management capitalisation. The Fund will invest at least 80% of its net assets, in investment approach in order to achieve its investment objective. securities of companies principally engaged in the research, Dealing: Shares of the Fund (“Shares”) are listed on one or more development, production, or distribution of products and services stock exchanges. Typically, only authorised participants (i.e., related to the health care industry. brokers) can purchase Shares from or sell Shares back to the Fund. Other investors can purchase and sell Shares on exchange on each Health care companies may include, for example, manufacturers day the relevant stock exchange is open. of health care equipment and supplies, health care services Distribution policy: Income received by the Fund’s investments providers, pharmaceutical companies, biotechnology and life will not be distributed in respect of the Shares of this class. Instead, sciences companies, and suppliers of technologies for use by it will be accumulated and reinvested on behalf of the health care companies.shareholders of the Fund. Recommendation: This Fund may not be appropriate for short- The following characteristics will be considered in the Fund’s term investment. construction: • Superior company management;Currency: The base currency of the Fund is US Dollar. • Significant insider ownership For full investment objectives and policy details, please refer to the • Unique market positions and broad marketSupplement. Risk and Reward Profile Lower risk Higher riska significant portion of its assets in the securities of companies Typically lower rewardsTypically higher rewards of a particular sector, it is more likely to be impacted by events or conditions affecting that sector. The Fund may invest a12 34 56 7 relatively large percentage of its assets in particular sectors, including the healthcare and technology sectors The categorisation above is not guaranteed to remain ▪Currency risk: The Fund invests in securities denominated in unchanged and may shift over time. currencies other than its base currency. Changes in the exchange rates may adversely affect the performance of the The lowest category (1) does not imply a risk-free investment. Fund. The risk indicator was calculated incorporating simulated Risks not covered by the indicator, but which are materially relevant historical data and may not be a reliable indication of the futureto the Fund include: risk profile of the Fund. ▪Liquidity on secondary market risk: There can be no certainty The categorisation above (6) is due to the nature of the Fund’sthat Shares can always be bought or sold on a stock exchange investments and risk associated with those investments,or that the market price will reflect the NAV of the Fund. including: For a complete overview of all risks attached to this Fund, refer ▪ The value of underlying securities can be affected by daily to the section entitled “Risk Factors” in the Supplement andfinancial market movements. Other influential factorsthe Prospectus.include political, economic news, company earnings andsignificant corporate events. ▪ There is no assurance that any appreciation in the value ofinvestments will occur, or that the investment objective ofthe Fund will be achieved. ▪ Active Management Risk: The Funds assets will be activelymanaged by the Investment Manager who will havediscretion (subject to the Sub-Fund’s investmentrestrictions) to invest the Fund’s assets in investments thatit considers will enable the Sub-Fund to achieve itsinvestment objective. There is no guarantee that the Sub-Fund’s investment objective will be achieved based on theinvestments selected. ▪ Sectoral Investment Risk: To the extent that the Fund invests Charges The charges you pay are used to pay the costs of running the Fund, including As the Fund is an ETF, secondary market investors will not the costs of marketing and distributing it. These charges reduce the potential typically be able to deal directly with HANetf ICAV. growth of your investment. Investors buying Shares on exchange will do so at marketprices which will reflect broker fees and/or transactionsOne-off charges taken before or after you investcharges and bid-ask spreads.Entry charge 0%** Authorised participants dealing directly with the FundExit charge 0%*will pay related transaction costs.* For Investors dealing directly with the Fund, switchingbetween sub-funds may incur a maximum switchingCharges taken from the Fund over a yearcharge of 3%.Ongoing charges 0.89%** ** The ongoing charges may vary year on year. It excludesportfolio transaction costs, except in the case of anCharges taken from the Fund under certain specific entry/exit charge paid by the Fund when buying or sellingconditions units in another investment fund.Performance feeNone The Fund may engage in securities lending, whereby 70%of the revenues arising from securities lending will be * Authorised participants dealing directly with the Fund may pay an entry returned to the Fund and 30% of the revenues will be charge up to a maximum of 5% and an exit charge up to a maximum of 3%. retained by the Manager and securities lending agent. The Fund is currently not exercising its entitlement to apply entry and exit Please see "General Charges and Expenses" and charges. "Management Charges and Expenses" sections of theProspectus and "Charges and Expenses" and "KeyInformation for Share Dealing" sections of theSupplement for further information about charges. Past Performance • Fund launch date: 4th April 2019 • Share class launch date: 4th April 2019 • The base currency of the fund is USD • Past performance of the Share Class is calculated in USD • The index changed from Indxx Advanced Life Sciences & Smart Healthcare Thematic Index to Indxx Global NextGen Healthcare Index on 9th April 2021. • The investment strategy and policy changed on 12 September 2024. Prior to this date the fund was passively managed and tracked the Indxx Global NextGen Healthcare Index . After this date the fund became actively managed. Index performance prior to any changes are displayed in the illustration • Performance is calculated based on the net asset value of the Fund after deduction of ongoing charges and is inclusive of gross income reinvested. • Past performance is not a guide to future performance Practical Information Investment Manager: Harbor Capital Advisors, Inc. Switching: Switching of Shares between sub-funds of Depositary: J.P. Morgan SE - Dublin Branch.HANetf ICAV is not possible for investors who purchase Administrator: J.P. Morgan Administration Services (Ireland) Limited. shares on exchange. Switching may be available to Further information: Copies of the Prospectus documentation and the latest authorised participants who deal directly with the Fund. financial statements are available free of charge from the Administrator. The Segregated liability: The Fund is a sub-fund of HANetf Prospectus and financial statements are prepared for HANetf ICAV rather than ICAV, an umbrella Irish collective asset-management separately for the Fund. Further information on the composition of the vehicle. Under Irish law the assets and liabilities of the portfolio is available at www.HANetf.com. Fund are segregated from other sub-funds within HANetf Remuneration Policy: Details of the Manager’s remuneration policy, including ICAV and the assets of the Fund will not be available to a description of how remuneration and benefits are calculated and the satisfy the liabilities of another fund of HANetf ICAV. identitiesof the personsresponsible for awarding such Taxation: HANetf ICAV is resident in Ireland for taxation remuneration/benefits, can be accessed from the following website: purposes. Irish taxation legislation may impact on the www.hanetf.com. A paper copy of these policy details is also available free of personal tax position of an investor. charge from the Manager upon request. Liability statement: The Manager may be held liable solely Pricing information: The net asset value of the share class will be available on the basis of any statement contained in this document during normal business hours every business day at the office of the that is misleading, inaccurate or inconsistent with the Administrator and will be published daily on www.hanetf.com. relevant parts of the Prospectus. This Fund is authorised in Ireland and regulated by the Central Bank of Ireland. HANetf Management Limited is authorised in Ireland and regulated by the Central Bank of Ireland. This key investor information is accurate as at 19.02.2025